Hypothesis

Senescent myocytes release a SASP component that upregulates carnitine acetyltransferase (CrAT) expression and activity in adjacent non‑senescent muscle fibers, thereby enhancing mitochondrial acetylcarnitine buffering and fatty‑acid oxidation as a compensatory metabolic response.

Mechanistic Rationale

• Mitochondrial β‑oxidation drives senescence via acetyl‑CoA overload [3].
• Declining CrAT activity with age limits acetylcarnitine formation, impairing substrate switching and promoting mitochondrial inertia [5].
• SASP from transiently senescent cells can modulate metabolic pathways in neighbors; IL‑6 and GDF15 have been shown to influence fatty‑acid oxidation [2] [6].
• We propose that a yet‑unidentified SASP factor (e.g., miR‑23a‑3p or secreted FGF21) acts as a paracrine signal that transcriptionally activates CrAT in recipient myocytes.

Testable Predictions

1. Co‑culture of senescent C2C12 myotubes (induced by doxorubicin or irradiation) with naïve myotubes will increase CrAT mRNA and protein levels in the naïve cells compared with naïve‑naïve co‑culture.
2. Neutralizing the candidate SASP factor (using antibodies or siRNA) will abolish the CrAT up‑regulation observed in prediction 1.
3. Overexpressing CrAT in senescent cells will not affect the paracrine effect, indicating the signal originates from the SASP rather than intracellular CrAT levels.
4. In vivo, acute induction of senescence in mouse tibialis anterior (via p16‑3MR model) will elevate CrAT activity and acetylcarnitine pools in neighboring non‑p16‑expressing fibers, measurable by mass spectrometry.
5. Pharmacological inhibition of CrAT (using ST045849) will blunt the metabolic benefit (enhanced palmitate oxidation) seen in naïve myocytes co‑cultured with senescent cells.

Experimental Approach

• Cellular model: Generate senescent myotubes (C2C12) using 10 µM doxorubicin for 48 h; confirm senescence via SA‑β‑gal, p16^Ink4a^ up‑regulation, and SASP cytokine profiling.
• Co‑culture: Insert naïve myotubes in transwell inserts (0.4 µm) to allow soluble factor exchange only; harvest after 24 h.
• Readouts: qPCR and Western blot for CrAT; enzymatic CrAT activity assay; targeted LC‑MS for acetylcarnitine and free carnitine; Seahorse FAO flux.
• Intervention: Add neutralizing antibodies against IL‑6, GDF15, FGF21, or use siRNA libraries to screen for SASP mediators; validate hits with CRISPR knockout in senescent cells.
• In vivo: Employ p16‑3MR mice; administer AP20187 to induce senescence for 7 d; isolate contralateral muscle fibers via laser‑capture microdissection; measure CrAT activity and acylcarnitine species.

Falsifiability

If senescent myocytes fail to increase CrAT activity or acetylcarnitine levels in neighboring cells under any of the above conditions, and neutralizing SASP factors does not alter the outcome, the hypothesis would be refuted. Conversely, consistent augmentation of CrAT‑dependent metabolic flux would support the idea that senescent cells act as metabolic “hostage negotiators” by coordinating a carnitine‑shuttle‑based rescue response in surrounding tissue.

References (inline)

[1] [2] [3] [4] [5] [6] [7]